Oat β-glucan depresses SGLT1- and GLUT2-mediated glucose transport in intestinal epithelial cells (IEC-6)

Nutr Res. 2016 Jun;36(6):541-52. doi: 10.1016/j.nutres.2016.02.004. Epub 2016 Feb 18.

Abstract

Oat β-glucan consumption is linked to reduced risk factors associated with diabetes and obesity by lowering glycemic response and serum level of low-density lipoproteins. The purpose of this study was to identify the mechanism of action of oat β-glucan at the interface between the gut wall and the lumen responsible for attenuating glucose levels. We proposed that viscous oat β-glucan acts as a physical barrier to glucose uptake in normally absorptive gut epithelial cells IEC-6 by affecting the expression of intestinal glucose transporters. Concentration and time-dependent changes in glucose uptake were established by using a nonmetabolizable glucose analog 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-d-glucose. The effectiveness of nutrient transport in IEC-6 cells was shown by significant differences in glucose uptake and corresponding transporter expression. The expressions of glucose transporters sodium-glucose-linked transport protein 1 (SGLT1) and glucose transporter 2 (GLUT2) increased with time (0-60 minutes) and glucose levels (5-25 mmol/L). The suppression of glucose uptake and SGLT1 and GLUT2 expression by increasing concentrations (4-8 mg/mL) of oat β-glucan demonstrated a direct effect of the physical properties of oat β-glucan on glucose transport. These results affirmed oat β-glucan as a dietary agent for minimizing postprandial glucose and showed that modulating the activity of the key intestinal glucose transporters with oat β-glucan could be an effective way of lowering blood glucose levels in patients with diabetes.

Keywords: Diabetes; Glucose absorption; IEC-6 cells; Oat β-glucan; Soluble fiber; Viscosity.

MeSH terms

  • Actins / genetics
  • Actins / metabolism
  • Animals
  • Biological Transport / drug effects
  • Cell Survival / drug effects
  • Cells, Cultured
  • Epithelial Cells / drug effects*
  • Epithelial Cells / metabolism
  • Glucose / metabolism*
  • Glucose Transporter Type 2 / genetics
  • Glucose Transporter Type 2 / metabolism*
  • Intestinal Mucosa / metabolism
  • Intestines / cytology
  • Intestines / drug effects*
  • Postprandial Period / drug effects
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Sodium-Glucose Transporter 1 / genetics
  • Sodium-Glucose Transporter 1 / metabolism*
  • beta-Glucans / analysis
  • beta-Glucans / pharmacology*

Substances

  • Actins
  • Glucose Transporter Type 2
  • RNA, Messenger
  • Slc2a2 protein, rat
  • Slc5a1 protein, rat
  • Sodium-Glucose Transporter 1
  • beta-Glucans
  • beta-glucan, (1-3)(1-4)-
  • Glucose